- 川寧生物
- 11.480+0.190 (+1.683%)
盈利能力分析
- 4.938
- 14.289
- 7.499
- 2.361
- 5.038
- 3.405
- 9.163
- 4.146
- 1.149
- 2.311
- 3.751
- 9.985
- 4.487
- 1.243
- 3.265
邊際利潤分析
- 34.419
- 31.574
- 24.798
- 22.213
- 21.590
- 27.785
- 23.249
- 14.268
- 6.919
- 7.635
- 28.531
- 24.434
- 15.983
- 9.649
- 12.521
- 23.150
- 19.500
- 10.771
- 3.445
- 6.275
收益指標分析
- 100.630
- 105.081
- 118.651
- 169.124
- 99.022
- -0.850
- -1.318
- -1.837
- 2.898
- 0.755
- -0.310
- -0.330
- -11.790
- -66.783
- -0.932
償債能力分析
- 1.761
- 1.560
- 1.672
- 1.255
- 1.381
- 1.213
- 0.899
- 1.161
- 0.688
- 0.778
- 30.648
- 31.220
- 40.229
- 49.508
- 52.966
- 20.704
- 21.568
- 35.033
- 44.967
- 49.241
- 369.009
- 349.970
- 184.124
- 121.635
- 102.908
- 225.890
- 219.900
- 148.436
- 101.858
- 88.685
- 34.308
- 19.374
- 4.964
- 1.754
- 2.526
營運能力分析
- 46.368
- 60.668
- 78.132
- 89.692
- 100.670
- 136.815
- 166.893
- 177.739
- 207.786
- 180.590
大國博弈
貨幣攻略
More